Literature DB >> 15246966

Inflammation and Cancer V. Chronic pancreatitis and pancreatic cancer.

David C Whitcomb1.   

Abstract

Pancreatic inflammation appears to increase the risk of pancreatic cancer. This observation is striking in the hereditary pancreatitis kindreds but also occurs in alcoholic, idiopathic, and tropical chronic pancreatitis and cystic fibrosis. However, the mutations associated with hereditary pancreatitis or cystic fibrosis are not found in sporadic pancreatic adenocarcinomas, suggesting that the effects are indirect by causing recurrent pancreatitis and chronic inflammation. The process of mutation accumulation and clonal expansion that is required for development of invasive pancreatic adenocarcinoma must therefore be accelerated in chronic pancreatitis to account for the high incidence of pancreatic cancer in these patients.

Entities:  

Mesh:

Year:  2004        PMID: 15246966     DOI: 10.1152/ajpgi.00115.2004

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  68 in total

1.  Aberrant signaling pathways in pancreatic cancer: a two compartment view.

Authors:  Angela L McCleary-Wheeler; Robert McWilliams; Martin E Fernandez-Zapico
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Nuclear factor (erythroid-derived 2)-like 2 regulates drug resistance in pancreatic cancer cells.

Authors:  Young Bin Hong; Hyo Jin Kang; Sun Young Kwon; Hee Jeong Kim; Kun Young Kwon; Chi Heum Cho; Jong-Min Lee; Bhaskar V S Kallakury; Insoo Bae
Journal:  Pancreas       Date:  2010-05       Impact factor: 3.327

3.  Role of parathyroid hormone-related protein in the pro-inflammatory and pro-fibrogenic response associated with acute pancreatitis.

Authors:  Vandanajay Bhatia; Sung O K Kim; Judith F Aronson; Celia Chao; Mark R Hellmich; Miriam Falzon
Journal:  Regul Pept       Date:  2012-01-23

Review 4.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

5.  Risk factors for pancreatic cancer: case-control study.

Authors:  Manal M Hassan; Melissa L Bondy; Robert A Wolff; James L Abbruzzese; Jean-Nicolas Vauthey; Peter W Pisters; Douglas B Evans; Rabia Khan; Ta-Hsu Chou; Renato Lenzi; Li Jiao; Donghui Li
Journal:  Am J Gastroenterol       Date:  2007-08-31       Impact factor: 10.864

6.  Utility of different serum fibrosis markers in diagnosing patients with chronic pancreatitis and pancreatic adenocarcinoma.

Authors:  Anna Kozak; Renata Talar-Wojnarowska; Aleksandra Kaczka; Anna Borkowska; Leszek Czupryniak; Ewa Małecka-Panas; Anita Gąsiorowska
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

Review 7.  Potential role of chitinase 3-like-1 in inflammation-associated carcinogenic changes of epithelial cells.

Authors:  Katrin Eurich; Mayuko Segawa; Satoko Toei-Shimizu; Emiko Mizoguchi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

8.  BMP2 inhibits TGF-β-induced pancreatic stellate cell activation and extracellular matrix formation.

Authors:  Xuxia Gao; Yanna Cao; Wenli Yang; Chaojun Duan; Judith F Aronson; Cristiana Rastellini; Celia Chao; Mark R Hellmich; Tien C Ko
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-02-21       Impact factor: 4.052

Review 9.  Alcohol consumption on pancreatic diseases.

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Jesus Maria Bañales; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2013-02-07       Impact factor: 5.742

10.  Notch and Kras in pancreatic cancer: at the crossroads of mutation, differentiation and signaling.

Authors:  Jean-Paul De La O; L Charles Murtaugh
Journal:  Cell Cycle       Date:  2009-06-15       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.